Rapid Therapeutic Science Laboratories, Inc. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net income was USD 0.191271 million compared to net loss of USD 1.58 million a year ago. Basic earnings per share from continuing operations was USD 0.02 compared to basic loss per share from continuing operations of USD 0.2 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 USD | 0.00% | 0.00% | +21.95% |
1st Jan change | Capi. | |
---|---|---|
+21.95% | 94.93K | |
+42.64% | 6.38B | |
-15.52% | 4.59B | |
+8.35% | 3.39B | |
-11.10% | 3.2B | |
-4.12% | 2.52B | |
+46.46% | 2B | |
-7.97% | 1.7B | |
-1.07% | 1.65B | |
-11.56% | 1.58B |
- Stock Market
- Equities
- RTSL Stock
- News Rapid Therapeutic Science Laboratories, Inc.
- Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023